StockData
Cocrystal Pharma, Inc. logo

Cocrystal Pharma, Inc. (COCP) stock

COCPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.98−0.03 (-3.28%)

Close on Nov 18, 2026Market cap $18.82MP/E –Yield –

Cocrystal Pharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Cocrystal Pharma's pe ratio was 96.7× on Jan 31, 2019.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Jan 31, 201996.7×−23.3
2018Dec 31, 2018120.0×–

More Cocrystal Pharma figures

See a number that looks wrong?